Activation of CEACAM1 with an Agonistic Monoclonal Antibody Results in Inhibition of Melanoma Cells

Researchers assessed the expression of carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) on four different human melanoma cell lines by western blot and flow cytometry and determined its effect on cell viability in vitro by MTT assay.